Literature DB >> 30446310

Targeting tyrosine kinase: Development of acridone - pyrrole - oxindole hybrids against human breast cancer.

Manpreet Kaur1, Palwinder Singh2.   

Abstract

Based on the molecular modelling studies, a rational modification of the lead molecule was made to develop highly potent compounds showing anti-cancer activity against human breast cancer cell lines MCF 7, MDA-MB-468 and T-47D. The most potent compounds have Log P and total polar surface area 4.4-5.4 and 59.8 Å, respectively and they also exhibited promising ADME profile.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acridone; Anticancer; Molecular modeling; Oxindole; Pyrrole; Tyrosine kinase

Mesh:

Substances:

Year:  2018        PMID: 30446310     DOI: 10.1016/j.bmcl.2018.11.021

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Syntheses, in vitro, and in silico studies of rhodanine-based schiff bases as potential α-amylase inhibitors and radicals (DPPH and ABTS) scavengers.

Authors:  Samuel Attah Egu; Irfan Ali; Khalid Mohammed Khan; Sridevi Chigurupati; Urooj Qureshi; Uzma Salar; Muhammad Taha; Shatha Ghazi Felemban; Vijayan Venugopal; Zaheer Ul-Haq
Journal:  Mol Divers       Date:  2022-05-23       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.